Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DJ74CB
|
|||
Drug Name |
VK-0214
|
|||
Synonyms |
6FGG71NJ3Y; VK0214; VK-0214; UNII-6FGG71NJ3Y; (((4-(3-Benzyl-4-hydroxybenzyl)-3,5-dimethylphenyl)oxy)methyl)phosphonic acid; ((4-(3-Benzyl-4-hydroxybenzyl)-3,5-dimethylphenoxy)methyl)phosphonic acid; Phosphonic acid, P-((4-((4-hydroxy-3-(phenylmethyl)phenyl)methyl)-3,5-dimethylphenoxy)methyl)-; 852949-30-5; SCHEMBL283442; CHEMBL4802139
Click to Show/Hide
|
|||
Drug Type |
Small molecule
|
|||
Indication | X-linked Adrenoleukodystrophy [ICD-11: 5C57] | Phase 1 | [1] | |
Company |
Viking Therapeutics San Diego, CA
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H25O5P
|
|||
Canonical SMILES |
CC1=CC(=CC(=C1CC2=CC(=C(C=C2)O)CC3=CC=CC=C3)C)OCP(=O)(O)O
|
|||
InChI |
InChI=1S/C23H25O5P/c1-16-10-21(28-15-29(25,26)27)11-17(2)22(16)14-19-8-9-23(24)20(13-19)12-18-6-4-3-5-7-18/h3-11,13,24H,12,14-15H2,1-2H3,(H2,25,26,27)
|
|||
InChIKey |
GFJCILQBXUTOGN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Thyroid hormone receptor beta (THRB) | Target Info | Agonist | [2] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Thyroid hormone signaling pathway | ||||
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | |||
Reactome | Nuclear Receptor transcription pathway | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Hematopoietic Stem Cell Differentiation | ||||
Nuclear Receptors |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT04973657) Phase 1b, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety, Tolerability, PD and PK of VK0214, in Subjects With the Adrenomyeloneuropathy Form (AMN) of X-linked Adrenoleukodystrophy (X-ALD). U.S.National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of Viking Therapeutics |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.